Trial Profile
Pharmacokinetics in Plasma and Saliva of a Single Dose Immediate- or Extended Release Methylphenidate in Healthy Volunteers.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Nov 2012
Price :
$35
*
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacogenomic; Pharmacokinetics
- Acronyms MPH-PK
- 23 Jun 2011 New trial record